ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growth.

Claire E Tocheny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.